Small caps taking on the world
Small caps taking on the world
About this video
Luke Winchester of Merewether Capital draws attention to investment opportunities in Australian small-cap companies seeking global growth. He highlights three growing players from the healthcare and technology sectors that demonstrate potential to succeed on the international stage, contrary to the scepticism surrounding Australian companies making overseas ventures.
The first company on his radar is Austco Healthcare (ASX:AHC), a clinical workflow and nurse call systems company, which enjoys 75% of its revenue coming from overseas. Luke notes a recent partnership with Premier Incorporated in the United States, a connection which pre-approves terms for Osco's systems, streamlining their entry into a network of around 4400 hospitals. He views this as a validation of Osco's progress from a tier-two contender to a top-tier competitor in their sector.
Luke further highlights Compumedics (ASX:CMP) and AI Media (ASX:AIM). Compumedics, a brain and sleep diagnostics company, recently launched their Som Fit product in Australia, a non-invasive device offering advanced sleep diagnosis. With 50% of the company's revenue being International, he sees substantial growth potential in the American market. AI Media, an automated captioning service provider, is noted for comprising more than just captioning services as it also controls a dominant captioning network. Despite concerns about automated captioning potentially dominating the industry and threatening existing businesses, Luke lauds AI Media's strategy to ride this wave towards more advanced technology.
Unedited transcript below
0:00
Let's get back into the smoke. Well, Luke Winchester now joining us, familiar with the capital to talk us through three small caps that are, well, essentially taking on the world. Luke,
0:09
thanks for joining us. So, uh, interesting, because we often talk about this, that Australian companies that do, well establish a good foothold here and then have these global ambitions. Quite often they fall short. So what do you look for?
0:24
They do. Andrew was the exact point. I was going to make the sort of intro the segment. I think investors are naturally skeptical whenever they see companies try to embark overseas. You know, there is a graveyard of companies who have attempted it, and usually by acquisition is when they fail. But it's just a fact of life. I mean, we're a small company in the green, sorry, small country in the grand scheme of things. You know, 2% of the world's, you know, markets, GDP, uh, whatnot. Um, and for many businesses, the Australian, the Australian population is just not enough. Um, and they need to, to go overseas to, to sort of chase those opportunities. And um, we normally associate that with large companies. They've got the balance sheet and the operations to do it. But you know, in the smaller end where I play, there's plenty of examples of companies taking on the world. And so I wanted to grab a couple and bring them to the program today. All right. Let's get into the first one being in health care. In fact, we were just talking about this earlier and the growth in healthcare, not the least, of course, being the the aging population. Um, which one are you looking at? Yeah. Look, Osco Healthcare, it's what I've spoken about a lot in in a sentence. It's nurse call
1:24
systems and clinical workflow. Um, as I said, anyone can use a search bar on us. Visit and find me talking about the stock, but, um, about about, uh, 75% or so of their revenues come from overseas right now. And I expect that gap to only increase over time. Uh, they had an announcement a couple of weeks ago as a Friday afternoon, which can sometimes sneak by the market on the Friday afternoon. Long lunches. Uh, but these guys announced a deal with an alliance called Premier Incorporated over in the States. Um, it's an alliance of about 4400 hospitals. Um, and then, you know, several hundred thousand allied health professionals as well. Um, and what that announcement was was for a pre-approved buying negotiation. So basically pre-approved terms for, for Roscoe's, um, you know, nurse call systems and clinical workflow software and essentially allows them to approach any of the 4400 hospitals within that premier incorporated alliance on those pre negotiated terms, and just starts the sales conversation at a much more
2:24
advanced place. Um, beyond that, and also, you know, it's product validation, these sorts of buying groups when they negotiate on behalf of their members, um, you know, they'll generally only go for for the best solutions that are sort of, as I said, pre-approved and pre negotiated. Um, that sort of validates what Osco has been trying to do for a couple of years. They sort of acknowledged that 2 or 3 years ago that their product was in that second, third tier of competition in the space, and they really invested quite heavily in their in their product set and their technology to bring it up to that tier one and, and really compete with the big guys on the scene. So I thought there's a really interesting, uh, um, announcement, as I said Friday afternoon, got by the market, no immediate dollars as well. It's one of those ones where it sets the platform for them to go and attack, you know, the the buying group. But, um, one, I think that's very good validation and it really can accelerate that international growth path in that massive US market for for Osco. All right. And another one that you have in your portfolio, uh, also in the health space. It's a medtech company. Cosmetics. Yeah.
3:23
Company medic. So again another small cap health healthcare company. These guys do do brain and sleep diagnostics. And um, it's a small niche but one they've they've sort of been, you know, had a dominant position in for some time, um, particularly from a technology point of view. Uh, now the opportunity for these guys, again, they're about 50% right now of their revenue internationally. And I think they can really grow that over time. Um, like Osco particularly that that US market looks quite attractive. And the reason why, I mean, it got a lot of publicity from from ResMed investors, you know, looking at large cap ResMed, uh, when their key competitor Philips pulled out of the US market, it wasn't just CPAp machines. Philips also had a 40% market share in sleep diagnostics as well. And they've backed out of that US market. They've they've seen support of their key product lines and will no longer, um, you know, manufacture and support that market. Uh, and to be honest, a bit like, you know, ResMed with the CPAp, that announcement caught the industry a little bit by surprise. They weren't expecting that at the time. And it's left a lot of those sleep clinics and pharmacy based sleep testing
4:23
scrambling for a solution. So enter compute medics. Um, these guys have come up with a new product called Som Fit, which has recently received FDA approval back end of last year. Um, they've launched it in Australia and had a pretty good uptake with it. They're trying to go through the pharmacy based sleep testing providers. They've got about a 75% market share. They're already mostly on the back of, um, distribution agreements and partnerships. Uh, but but what this product really does is that the classic sleep testing, when you go into a clinic, um, you know, wires are strapped all around your body and your face and, um, test all sorts of things. But the Som fit machine is just a small pendant that's strapped to the strap to the forehead of the patient, um, and tracks their brain activity as they sleep. So, you know, there's a lot of, um, conjecture around the fact that having all those wires over your body while you do a sleep test in and of itself, disrupts your sleep. So are you getting a, you know, proper reading of somebody's sleep patterns when they're covered in wires and, and whatnot. Um, so these sorts of wireless.
5:23
Solutions. Very small, very, you know, non-invasive, um, certainly appears to be the future of that sleek testing industry. So exciting for computer medics. There's a big gap in the market for them to attack. No guarantees. Of course we know this with micron small caps, but management's excited about the opportunity. They've beefed up their sales team in the US and they're trying to attack it right now. So yeah um again one one we're excited for. And hopefully they can get some runs on the board. Yeah fascinating and growing space as you pointed out there, Luke. Uh, finally there, your third stock is eye media. And I think we've spoken about this before. It's, uh. Well, clearly, um, it's got a beneficial name, hasn't it? Although you're saying that this is established well before the AI mania.
6:05
Yeah. The AI stands for, uh, access innovation, I believe. Um, so. But it ties into it to AI as well. And that's where we've spoken about it before. Again, I won't take too long. People can can search and find me talking about in the past, but effectively captioning services. And I think what gets lost with this business is, um, you know, captioning and human based captioning is being completely disrupted by speech to text engines, and, um, automated captioning is, you know, now starting to dominate that industry. And I think will, uh, effectively supersede human based captioning in just a number of years. Um, and I think that causes the market to sometimes look at AI media and think, this is a business in terminal decline, but sort of through the forest, through the trees here is, um, these guys own more than just the captioning services. They actually own the dominant, uh, captioning network provider, uh, in particular in the US, but now looking to expand globally. So again, about two thirds of their revenue coming from overseas fitting in with this, this theme we've got of taking on the world. Um, but what excites me here is that, as I've said before, uh,
7:05
putting captions on a screen is not just the same as pointing an AI tool in a video feed or an audio feed. Um, you know, there needs to be an encoding network, uh, encrypted, all sorts of, uh, you know, things in the background which AI media owns and controls. And as I said, has that dominant position in. So they're riding that wave as I starts to dominate this captioning and and bring more use cases to market. It's only growing the pie for AI media to attack. And they have their own automated solution as well. You know they obviously looking to back that on to what they're doing with their with their network that they own. Um, but one I think could be very exciting over the next few years. And uh, one of the few businesses, I think, on the ASX where, you know, AI is a is a genuine beneficiary to them and not a potential disruptor. So I think it's quite exciting and one I think worth digging into for, for any small cap investor.